Valneva (VALN) stock rose after the company posted new Phase 3 trial data for its chikungunya vaccine, Ixchiq, in adolescents aged 12-17. Read more here.

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Although not listed as a hemorrhagic fever virus, illness caused by CHIKV can ... A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since ...

Maharashtra witnessed a significant rise in chikungunya cases this year, with 5,757 infections. Patients are experiencing prolonged after-effects like joint pain, fatigue, and neurological ...

The existing RT-PCR test systems are time consuming and labor-intensive, with a very high risk of contamination primarily due to post-PCR handling leading to carry over. In addition, the majority ...

Now, researchers used cryoelectron microscopy (cryo-EM) to elucidate the structure of the Nipah virus polymerase complex (the ...

Researchers have profiled the molecular structure and features of a key part of the deadly Nipah virus. Experiments in cells showe how changes in the viral polymerase -- a protein involved in viral ...

The work provides a detailed three-dimensional picture of the virus's polymerase and its key features. Understanding the ...

Infected mosquitoes spread the chikungunya virus through their bites. The main transmitters are the Aedes aegypti and Aedes albopictus species. The same 2 species of mosquitoes also transmit dengue.

HMPV causes flu-like symptoms. The virus usually affects the upper respiratory system but can sometimes cause lower respiratory infections. HMPV is more common in winter and early spring.

A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and ...